Georgia Research Alliance Names First Eminent Scholar in Nanomedicine

Primary tabs

Younan Xia, an internationally recognized leader in the field of nanotechnology, recently joined the Georgia Institute of Technology as the first Georgia Research Alliance (GRA) Eminent Scholar in Nanomedicine.

Xia is the Brock Family Chair and GRA Eminent Scholar in Nanomedicine in the Wallace H. Coulter Department of Biomedical Engineering at Georgia Tech and Emory University, with a joint appointment in the School of Chemistry and Biochemistry. His research focuses on nanocrystals -- a novel class of materials with features smaller than 100 nm -- as well as the development of innovative technologies enabled by nanocrystals. These technologies span the fields of molecular imaging, early cancer diagnosis, targeted drug delivery, biomaterials, regenerative medicine and catalysis.

“The possible applications of nanotechnology in medicine have only begun to be explored, said Michael Cassidy, President and CEO of the Georgia Research Alliance. “Dr. Xia’s expertise and collaborative vision will lead to vital new scientific discoveries that can be transformed into new tools to help people live healthier lives.”

Xia received his Ph.D. in physical chemistry from Harvard University in 1996, his M.S. in inorganic chemistry from University of Pennsylvania (with the late Professor Alan G. MacDiarmid, a Nobel Laureate in Chemistry, 2000) in 1993. He has received a number of prestigious awards, including AIMBE Fellow (2011), MRS Fellow (2009), NIH Director's Pioneer Award (2006), Leo Hendrik Baekeland Award (2005), Camille Dreyfus Teacher Scholar (2002), David and Lucile Packard Fellowship in Science and Engineering (2000), Alfred P. Sloan Research Fellow (2000), NSF Early Career Development Award (2000) and the ACS Victor K. LaMer Award (1999).

“Dr. Xia is a world-renowned teacher and leader at the forefront of nanomedicine and materials science,” said Larry McIntire, the Wallace H. Coulter Chair of Biomedical Engineering. “His reputation and innovative research in these areas will clearly strengthen our expanding efforts in nanomedicine and biomaterials. We are honored to welcome him to the department and to the Institute.”



  • Workflow Status:
  • Created By:
    Liz Klipp
  • Created:
  • Modified By:
    Fletcher Moore
  • Modified:

Target Audience

    No target audience selected.